Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Dr Laura Kolbe joins Ethics Talk to discuss her article, coauthored with Drs Ryan H. Nelson, Joelle Robertson-Preidler, Olivia Schuman, and Inmaculada de Melo-Martín: “Is a Video Worth a Thousand Words?”
Dr Esha Bansal joins Ethics Talk to discuss her article, coauthored with Drs Saran Kunaprayoon and Linda P. Zhang: “Opportunities for Global Health Diplomacy in Transnational Robotic Telesurgery.”
Colonel Paul F. Pasquina, USA (Ret), MD, Antonio J. Carvalho, and Terrence Patrick Sheehan, MD
Health outcomes for people who have had amputations are affected not only by barriers to access, such as race, socioeconomic status and cost, but also by the type of facility where they receive treatment and rehabilitative services.
AMA J Ethics. 2015;17(6):535-546. doi:
10.1001/journalofethics.2015.17.6.stas1-1506